Tonghua Mao Xiang Pharmaceutical Co., Ltd.

This product is a broad-spectrum semi-synthetic penicillin with extremely low toxicity. The antibacterial spectrum is similar to that of penicillin, and it has a strong antibacterial effect on grass-green streptococci, hemolytic streptococci, and enterococci. Diphtheria bacillus, anthrax bacillus, Gram-positive anaerobic cocci and bacilli are sensitive to this product; meningococci, pertussis bacilli, and Brucella are also very sensitive. Escherichia coli, Salmonella, Shigella dysenteriae, Proteus, influenza bacilli, pneumococci, gonococci, etc., all have varying degrees of drug resistance because some strains produce beta-lactamase. Among them, the resistance rate of Escherichia coli is as high as 50-60%. Enterobacter bacteria, Pseudomonas aeruginosa, and anaerobic Gram-negative bacilli are resistant to this product. This product is mainly used to treat infectious diseases caused by sensitive Staphylococcus aureus, hemolytic streptococci, gonococci, meningococci and diphtheria Bordetella, pertussis Bordetella, influenza Bordetella, Salmonella, Shigella, etc.; such as respiratory tract infections (pneumonia, acute and chronic bronchitis, whooping cough, etc.), gastroenteritis and digestive tract infections (liver and gallbladder infections, acute and chronic gastroenteritis, bacillary dysentery, typhoid and paratyphoid, etc.), urinary tract infections (gonorrhea, urethritis, cystitis, etc.), soft tissue infections and sepsis, meningitis, endocarditis, etc.

This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes. It has antibacterial effects on dermatophytes, Candida, etc., and also has a certain effect on some Gram-positive cocci.

Improve microcirculation, increase coronary sinus blood flow, improve hypoxia tolerance, slow down heart rate, and resist ulcers

Improve microcirculation, increase coronary sinus blood flow, improve hypoxia tolerance, slow down heart rate, and resist ulcers

Improve microcirculation, increase coronary sinus blood flow, improve hypoxia tolerance, slow down heart rate, and resist ulcers

Improve microcirculation, increase coronary sinus blood flow, improve hypoxia tolerance, slow down heart rate, and resist ulcers

Improve microcirculation, increase coronary sinus blood flow, improve hypoxia tolerance, slow down heart rate, and resist ulcers

This product is a broad-spectrum semi-synthetic penicillin with extremely low toxicity. The antibacterial spectrum is similar to that of penicillin, and it has a strong antibacterial effect on grass-green streptococci, hemolytic streptococci, and enterococci. Diphtheria bacillus, anthrax bacillus, gram-positive anaerobic cocci and bacilli are sensitive to this product; meningococci, pertussis bacillus, and brucella are also very sensitive. Escherichia coli, Salmonella, Shigella dysenteriae, Proteus, influenza bacillus, pneumococci, gonococci, etc. have different degrees of drug resistance because some strains produce beta-lactamase. Among them, the drug resistance rate of Escherichia coli is as high as 50-60%. Enterobacter bacteria, Pseudomonas aeruginosa and anaerobic Gram-negative bacilli are resistant to this product. It is mainly used to treat infectious diseases caused by sensitive Staphylococcus aureus, hemolytic streptococci, gonococci, meningococci, diphtheria bacillus, pertussis bacillus, influenza bacillus, Salmonella, Shigella, etc.

This product is a derivative of fluorouracil. It is activated by the liver in the body and gradually converted into fluorouracil to play an anti-tumor role. It can interfere with and block the synthesis of DNA, RNA and protein, and mainly acts on the S phase. It is a cell cycle-specific drug of anti-pyrimidine. Its mechanism of action, efficacy and anti-tumor spectrum are similar to those of fluorouracil, but it has a long-lasting effect, good absorption and low toxicity. The chemotherapy index is twice that of fluorouracil, and the toxicity is only 1/4 to 1/7 of that of fluorouracil. No serious bone marrow suppression was observed in the chronic toxicity experiment, and the effect on immunity was relatively mild.